HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Teresa Melo Selected Research

Therapeutics

8/2019Recommendations from a Portuguese Expert Group for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients in Clinical Practice.
11/2012Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Teresa Melo Research Topics

Disease

4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2019 - 11/2012
1Leukemia
01/2014
1Hemorrhage
04/2003
1Transient Ischemic Attack
04/2003
1Cerebral Infarction
04/2003
1Stroke (Strokes)
04/2003

Drug/Important Bio-Agent (IBA)

3Tyrosine Kinase InhibitorsIBA
08/2019 - 11/2012
1InterferonsIBA
01/2014
1KIR ReceptorsIBA
11/2012
1Dasatinib (BMS 354825)FDA Link
11/2012
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
04/2003
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2003
1triflusalIBA
04/2003

Therapy/Procedure

2Therapeutics
08/2019 - 11/2012